We've found
4,132 Diabetes
clinical trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Glooko mHealth Advantage Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Pharmacology / Toxicology Clinical Trial
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Clinical Trial
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Retinopathy Clinical Trial
A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
Status: Enrolling,
Phase
IV
Updated: 4/24/2018
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
Status: Enrolling
Updated: 10/11/2017
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
Status: Enrolling,
Phase
I
Updated: 11/1/2017
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Evaluation of TTP399 in Patients With Type 1 Diabetes
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology Clinical Trial
Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gestational Diabetes Mellitus Clinical Trial
Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
4,132 Diabetes
clinical trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/31/1969
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
Updated: 3/22/2017
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
Updated: 3/22/2017
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
Status: Enrolling
Updated: 3/22/2017
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Updated: 12/31/1969
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Glooko mHealth Advantage Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Updated: 12/31/1969
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Heart Failure With Preserved Systolic Function Clinical Trial
Updated: 12/31/1969
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Clinical Trial
Updated: 12/31/1969
Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
Updated: 12/31/1969
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Retinopathy Clinical Trial
Updated: 12/31/1969
A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 4/24/2018
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
Status: Enrolling,
Phase
IV
Updated: 4/24/2018
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Updated: 10/11/2017
Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
Status: Enrolling
Updated: 10/11/2017
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 10/25/2017
Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients
Status: Enrolling
Updated: 10/25/2017
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 11/1/2017
Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
Status: Enrolling,
Phase
I
Updated: 11/1/2017
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Updated: 12/31/1969
Evaluation of TTP399 in Patients With Type 1 Diabetes
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Ophthalmology Clinical Trial
Updated: 12/31/1969
PROMINENT-Eye Ancillary Study (Protocol AD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus Aged 10 to Below 18 Years Old
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 1 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gestational Diabetes Mellitus Clinical Trial
Updated: 4/3/2018
Supporting American Indian/Alaska Native Mothers and Daughters in Reducing Gestational Diabetes Risk
Status: Enrolling
Updated: 4/3/2018
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials